Background-Patients with severe chronic obstructive pulmonary disease (COPD) have impairment in most areas of quality of life, but a relationship between impairment of the partial pressure of oxygen in arterial blood (Pao2) and quality of life has not been established. Previous studies used general health measures such as the Sickness Impact Profile (SIP). In this study a disease-specific health measure, the St George's Respiratory Questionnaire (SGRQ), was Patients with severe chronic obstructive pulmonary disease (COPD) complicated by chronic hypoxaemia complain of disabling breathlessness and reduced exercise capacity.' 2 In addition, they suffer from depression3 and impairment of cognitive function.4 Previous studies have shown that measures of lung function such as forced expiratory volume in one second (FEVy) do not accurately predict exercise capacity in these patients.56 In recent years health-related quality of life questionnaires have been developed to provide standardised measurements of disturbance to daily life and well being due to disease. These have been shown to provide valid measurements of impaired health in COPD. They reflect, and aggregate together, a range of aspects of disease activity and its resulting disability and distress.37 10 Unlike the FEV1, these measures correlate quite well with exercise capacity.3"7 12
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Background-Patients with severe chronic obstructive pulmonary disease (COPD) have impairment in most areas of quality of life, but a relationship between impairment of the partial pressure of oxygen in arterial blood (Pao2) and quality of life has not been established. Previous studies used general health measures such as the Sickness Impact Profile (SIP). In this study a disease-specific health measure, the St George's Respiratory Questionnaire (SGRQ), was used to examine the relationship. Methods -Forty one patients (20 men) of median age 71 years (range 47-85) with COPD were assessed. Forced expiratory volume in one second (FEVy), Pao2 and partial pressure of carbon dioxide in the arterial blood (Paco2) were measured, and the patients completed the SGRQ, SIP, and the Hospital Anxiety and Depression Scale (HAD). Results -The mean (SD) values were: FEV1, 0*83 (0.29) litres; Pao2, 7 .49 (103) kPa; Paco2, (1.05) kPa; SGRQ total score, 55*3 (18.2); SIP total score 15-4 (9.2); anxiety score, 5 7 (4.3); depression score, 5.3 (3.4) . Pao2 was significantly correlated with the SGRQ total scores but not with the SIP total score. The SGRQ total score also correlated with anxiety and depression. Multivariate analysis showed that depression score and Pao2 were both significant covariates of the SGRQ total score. Each patient was asked to complete three questionnaires: the SIP, SGRQ, and Hospital Anxiety and Depression scale (HAD) . All questionnaires were self-completed with supervision. The same person supervised administration of the questionnaires in all cases. Non-directive guidance was given on the few occasions when patients had queries about how to respond to the questionnaire.
Conclusions
The SIP has 136 response items which produce a range of summary component scores, including physical, psychosocial and an overall total score. Each of these scores ranges from 0 to 100%, a score of 0% indicating no disability. In a previous study almost all healthy control subjects matched for age, sex, and education with a group of patients with COPD had SIP summary scores of less than 10%."
The SGRQ has 76 items which are weighted to produce three component scores (symptoms, activity, and impact) and a total score. Each of these scores ranges from 0 to 100, a score of 100 indicating maximum disability.
The HAD is a 14 item instrument which produces separate scores for anxiety and depression ranging from 0 to 21; a score of over 10 is judged to be a predictor of a clinical diagnosis of anxiety or depression.
The three questionnaires were completed at one sitting in a randomised order. The patients also underwent spirometric tests and blood gas analysis at rest using arterialised earlobe capillary samples.'5 The whole assessment was repeated after an interval of two to three weeks, each patient using the same order of questionnaires as had been used at the first assessment.
The study was approved by the ethics committee of the Royal Brompton National Heart and Lung Hospitals, and all patients gave written informed consent to participation in the study. Pao2 (kPa) Anxiety showed significant correlations with SGRQ total score (r=0-50, p=0-001), SIP total score (r=0.44, p<0005), and was correlated with the Pao2 (r=0-36, p<0 05) but not with FEV, or Paco2. Depression was significantly related to SGRQ total score (r= 0-62, p<0001) and the SIP total score (r=0 59, p<0001). There was no significant correlation found between depression and any physiological variable (table 3) .
To test whether the relationship between Pao2 and SGRQ total score was related to other factors such as FEVI, Paco2 or mood state, a number of multivariate models were generated.
In a model incorporating Pao2 and FEV, the Pao2 was the only significant covariate of the SGRQ total score (p<005). A similar model including Pao2 and Paco2 again showed that Pao2 was the only significant covariate. In a model incorporating Pao2 and anxiety, Pao2 was a significant covariate of the SGRQ total (p<0 002) whereas anxiety was not. Finally, in a model incorporating Pao2 and depression both covariates were significant (Pao2, p<005; depression, p=000001). Discussion This is the first study to report a correlation between degree of hypoxaemia and quality of life scores in COPD. This correlation was statistically significant even though a relatively small number of patients was studied. The observation appears to have been due to the use of a questionnaire designed specifically for use in patients with airflow limitation. In this study, as in previous ones, attempts to correlate hypoxaemia with impaired health measured with a general health questionnaire failed.3 General health measures were developed to provide an estimate of impaired health due to a wide range of diseases. As a result, the proportion of items relevant to any particular disease may be low. A previous review of the SIP concluded that this instrument is relatively insensitive in patients with asthma and COPD because its scores remain in the mildly abnormal range until the FEVy falls below 50% of the predicted normal.'" Disease-specific questionnaires were developed because of the potential insensitivity of the general measures. All of the items in such questionnaires are relevant to the condition under study. Those included in the SGRQ were selected because they were relevant to the daily lives and well being of the patients, not because of a demonstrated relationship to a physiological variable. In view of this, we conclude that the correlation between hypoxaemia and SGRQ score was not due to an inbuilt bias in the questionnaire that would unduly have favoured a correlation with hypoxaemia. The detection of a correlation with this questionnaire was presumably due to the high content of items relevant to COPD. The correlation between Pao2 and quality of life was found on two separate occasions which makes it unlikely that this was a chance observation.
No significant correlations were found between FEVy and any quality of life score. Previous studies have also shown such relationships to be weak.89" In addition, there were no patients with an FEV, value of more than 1 5 litres in the current study so the range of measurements was small, making the detection of a weak correlation more difficult. Our finding of an association between quality of life and anxiety and depression confirms findings from other studies.37 ' 16 In general, anxiety and depression have been found to be better predictors of quality of life scores than physiological parameters. In this study, multivariate analysis showed that the effect of Pao2 on quality of life was independent of the effect of mood state.
Quality oflife questionnaires provide a standardised method of measuring the impact of disease on the health and well being ofpatients. They attempt a comprehensive coverage but, for reasons of length and practicality, they cannot address all of the possible disturbances that patients may suffer. Furthermore, they have been developed and validated in populations of patients and thus address areas of commonality between patients with the disease in question and do not provide a description of the precise manner in which each individual's life is disturbed. A distinction should therefore be drawn between the quality of life of an individual patient with COPD and the standardised estimate of their impaired health provided by a quality of life questionnaire. It is perhaps unfortunate that the term "quality of life" has been attached to this type of questionnaire. There are many influences upon the quality of life of an individual with COPD. The conclusion to be drawn from this study is that the level of hypoxaemia is one potentially influential factor and, furthermore, one that appears to be independent ofthe degree ofairways obstruction as measured by the FEV,.
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